AVAC Comments to FDA on Vaccine and Related Biological Product Advisory Committee May Meeting

Letters to Administration

AVAC comments provided to the Food and Drug Administration (FDA) in advance of the Vaccine and Related Biological Product Advisory Committee (VRBPAC) meeting on May 28, 2026.

Read the full letter.